Indivumed GmbH: Indivumed Launches the nRavel AI Platform for Cancer Research and Drug Development
First Pharma Companies Sign Collaboration Agreements, Announce Utilization of Novel PlatformHAMBURG, Germany, June 2, 2021 /PRNewswire/ -- Indivum...
Read full article »
Indivumed is a provider of tumor database and biospecimen products for biopharmaceutical companies and research institutes.
Read more